Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens

Parasitology International

Volumn 59, Issue 2, 2010, Pages 154-158

  Vendrametto, Michele Cristina ^a   Santos, Adriana Oliveira dos ^b   Nakamura, Celso Vataru ^a,b   Filho, Benedito Prado Dias ^a,b   Cortez, Diógenes Aparício Garcia ^a   Ueda Nakamura, Tânia ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Antileishmanial activity; Eupomatenoid 5; Leishmania amazonensis; Piper regnellii var. pallescens

Indexed keywords

ANTILEISHMANIAL AGENT; EUPOMATENOID 5; NEOLIGNAN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY TEST; DRUG ISOLATION; DRUG SPECIFICITY; ENDOPLASMIC RETICULUM; EXOCYTOSIS; FLAGELLUM; IC 50; LEISHMANIA; MACROPHAGE; NONHUMAN; PIPER REGNELLII; PIPERACEAE; PLANT LEAF; PRIORITY JOURNAL; PROMASTIGOTE; SOLVENT EXTRACTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTIPROTOZOAL AGENTS; BENZOFURANS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; PARASITIC SENSITIVITY TESTS; PHENOLS; PIPER; PLANT LEAVES;

LEISHMANIA AMAZONENSIS; PIPER REGNELLII; PROTOZOA;

EID: 77951620436     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2009.12.009     Document Type: Article

References (31)

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27 (2004) 305-318
2. Croft S.L., Seifert K., and Yardley V. Current scenario of drug development for leishmaniasis. Ind J Med Res 123 (2006) 399-410
3. Sereno D., Silva A.C., Mathieu-Daude F., and Ouaissi A. Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int 56 (2007) 3-7
4. World Health Organization. Urbanization: an increasing risk factor for leishmaniasis. Weekly epidemiological record, Geneva, v.77, n.44. 2002, p.365-370. Available in < http://www.who.int/wer>. Access in: 05.03.2009.
5. McConville M.J., and Handman E. The molecular basis of Leishmania pathogenesis. Int J Parasitol 37 (2007) 1047-1051
6. Natera S., Machuca C., Padrón-Nieves M., Romero A., Díaz E., and Ponte-Sucre A. Leishmania spp.: proficiency of drug-resistant parasites. Int J Antimicrob Agents 29 6 (2007) 637-642
7. Iwu M.M., Jackson J.E., and Schuster B.G. Medicinal plants in the fight against leishmaniasis. Parasitol Today 10 (1994) 65-68
8. Cronquist A. An integrated system of classification (1981), Columbia University Press, New York
9. Sengupta S., and Ray A.B. The chemistry of Piper species: a review. Fitoterapia LVIII 3 (1987) 147-166
10. Parmar V.S., Jain C.S., Bisht K.S., Jain R., Taneja P., and Jha A. Phytochemistry of the genus piper. Phytochemistry 46 (1997) 591-673
11. Santos P.R.D., Moreira D.L., Guimarães E.F., and Kaplan M.A.C. Essential oil analysis of 10 Piperaceae species from the Brazilian Atlantic forest. Phytochemistry 58 (2001) 547-551
12. Pessini G.L., Dias-Filho B.P., Nakamura C.V., Ferreira A.G., and Cortez D.A.G. Neolignans and the analysis of the essential oil of Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck leaves. Braz J Pharmacogn 15 3 (2005) 199-204
13. Luize P.S., Ueda-Nakamura T., Dias-Filho B.P., Cortez D.A.G., and Nakamura C.V. Activity of neolignans isolated from Piper regnellii (MIQ.) C. DC. var. pallescens (C. DC.) Yunck against Trypanosoma cruzi. Biol Pharm Bull 10 (2006) 2126-2130
14. Sartorelli P., Benevides P.J.C., Ellensohn R.M., Rocha M.V.A.F., Moreno P.R.H., and Kato M.J. Enantioseletive conversion of p-hydroxypropenylbenzene to (+)- conocarpan in Piper regnellii. Plant Sci 161 (2001) 1083-1088
15. Warren L.G. Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate. J Parasitol 46 (1960) 529-539
16. Ueda-Nakamura T., Attias M., and Souza W. Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study. Parasitol Res 87 (2001) 89-97
17. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assays for anticancer-drug screening. J Nat Canc Inst 82 (1990) 1107-1112
18. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., and Kortsaris A.H. Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods 208 (1997) 151-158
19. Nakamura C.V., Santos A.O., Vendrametto M.C., Luize P.S., Dias-Filho B.P., Cortez D.A.G., et al. Atividade antileishmania do extrato hidroalcoólico e de frações obtidas de folhas de Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck. Braz J Pharmacogn 16 1 (2006) 61-66
20. Pessini G.L., Dias-Filho B.P., Nakamura C.V., and Cortez D.A.G. Antibacterial activity of extracts and neolignans from Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck. Mem Inst Oswaldo Cruz 98 (2003) 1115-1120
21. Cunningham A.C. Parasitic adaptive mechanisms in infection by Leishmania. Exp Mol Pathol 72 (2002) 132-141
22. Luize P.S., Ueda-Nakamura T., Dias-Filho B.P., Cortez D.A.G., Morgado-Díaz J.A., and Souza W. Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi. Parasitol Res 100 (2006) 31-37
23. Koroishi A.M., Foss S., Cortez D.A.G., Ueda-Nakamura T., Nakamura C.V., and Dias-Filho B.P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J Ethnopharmacol 117 2 (2008) 270-277
24. Kafetz D.A., Velissariou I.M., Stabouli S., Mavrikou M., Delis D., and Liapi G. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?. Int J Antimicrob Agents 25 (2005) 26-30
25. Rodrigues J.C.F., Attias M., Rodriguez C., Urbina J.C., and Souza W. Ultrastructural and biochemical alterations induced by 22, 26-azasterol, a Δ24(25)-sterol methyltransferase inhibitor on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob Agents Chemother 46 2 (2002) 487-499
26. Rodrigues J.C., Urbina J.A., and Souza W. Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis. Exp Parasitol 111 4 (2005) 230-238
27. Granthon A.C., Braga M.V., Rodrigues J.C., Cammerer S., Lorente S.O., and Gilbert I.H. Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors. Vet Parasitol 15 146(1-2) (2007) 25-34
28. Ueda-Nakamura T., Mendonça-Filho R.R., Morgado-Díaz J.A., Maza P.K., Dias-Filho B.P., Cortez D.A.G., et al. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int 55 2 (2006) 99-105
29. Brenzan M.A., Nakamura C.V., Dias-Filho B.P., Ueda-Nakamura T., Young M.C.M., and Cortez D.A.G. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res 101 (2007) 715-722
30. Bera A., Singh S., Nagaraj R., and Vaidya T. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Mol Biochem Parasitol 127 1 (2003) 23-35
31. Tiuman T.S., Ueda-Nakamura T., Cortez D.A.G., Dias-Filho B.P., Morgado-Díaz J.A., Souza W., et al. Antileishmanial activity of parthenolide, a sesquiterpene lactona isolated from Tanacetum parthenium. Antimicrob Agents Chemother 49 (2005) 176-182